1/39
Looks like no tags are added yet.
Generic:
Clindamycin (oral)
Brand:
Cleocin
Generic:
Clindamycin (topical)
Brand:
Cleocin T
Generic:
Doxycycline
Brand:
Adoxa
Generic:
Metronidazole
Brand:
Flagyl (brand discontinued)
Generic:
Chlorhexidine Gluconate
Brand:
Peridex
Hibiclens
Generic:
Mupirocin
Brand:
Bactroban
Generic:
Nitrofurantoin
Brand:
Macrodantin
Macrobid
Generic:
Trimethoprim-sulfamethoxazole
Brand:
Bactrim
Generic:
Fluconazole
Brand:
Diflucan
Generic:
Ketoconazole
Brand:
Nizoral
Generic:
Nystatin (systemic)
Brand:
Bio-statin
Generic:
Nystatin (topical)
Brand:
Mycostatin
Nystop
Generic:
Clobetasol
Brand:
Temovate
Generic:
Prednisone
Brand:
Deltasone (brand discontinued)
Therapeutic Class:
Clindamycin (oral and tropical)
Lincosamide Antibiotic
Therapeutic Class:
Doxycycline
Tetracycline Antibiotic
Therapeutic Class:
Metronidazole
Nitroimidazole Antibiotic
Antiprotozoal
Therapeutic Class:
Chlorhexidine Gluconate
Antibacterial Cleansing Agent
Therapeutic Class:
Mupirocin
Therapeutic Class:
Topical Antibiotic
Therapeutic Class:
Nitrofurantoin
Nitrofuran Antibiotic
Therapeutic Class:
Trimethoprim-sulfamethoxazole
Sulfonamide Antibiotic
Therapeutic Class:
Fluconazole
Triazole Antifungal
Therapeutic Class:
Ketoconazole
Imidazole Antifungal
Therapeutic Class:
Nystatin (topical and systemic)
Polyene Antifungal
Therapeutic Class:
Clobetasol
Topical corticosteroid
Therapeutic Class:
prednisone
corticosteroid
Selected FDA Approval Indication:
Clindamycin (oral)
Infection of skin/ subcutaneous tissue
Lower respiratory tract infection
Selected FDA Approval Indication:
Clindamycin (topical)
Acne vulgaris
Selected FDA Approval Indication:
Doxycycline
Acne vulgaris
Staphylococcal infection of the skin
Selected FDA Approval Indication:
Metronidazole
Abscess
Selected FDA Approval Indication:
Chlorhexidine Gluconate
Gingivitis
Skin or wound cleansing
Selected FDA Approval Indication:
Mupirocin
Impetigo
Selected FDA Approval Indication:
Nitrofurantoin
Urinary tract infection
Selected FDA Approval Indication:
Trimethoprim-sulfamethoxazole
Urinary tract infection
Selected FDA Approval Indication:
Fluconazole
Candidiasis
Selected FDA Approval Indication:
Ketoconazole
Dandruff
Tinea corporis
Tinea cruris
Tinea pedis
Selected FDA Approval Indication:
Nystatin systemic
Oropharyngeal candidiasis
Selected FDA Approval Indication:
Nystatin topical
Candidiasis of skin
Selected FDA Approval Indication:
Clobetasol
Plaque psoriasis
Selected FDA Approval Indication:
Prednisone
Disorders due to an inflammatory response (e.g., asthma, ulcerative colitis, multiple sclerosis, rheumatoid arthritis)